Table 4.
Median (IQR) | RANTES | Ip10 | VEGF | TNF | IL-12p70 | IL-10 | IL-8 | IFN-γ | IL-4 |
---|---|---|---|---|---|---|---|---|---|
na | 31 | 36 | 44 | 39 | 39 | 43 | 40 | 32 | 38 |
Before | 0.85 (0.0 to 2.0) | 1.18 (0.1 to 2.5) | 3.63 (1.5 to 8.2) | 0.89 (0.4 to 1.7) | 0.66 (0.0 to 1.0) | 0.89 (0.2 to 1.5) | 1.24 (0.7 to 2.2) | 1.29 (0.0 to 1.8) | 0.70 (0.3 to 2.0) |
After | 1.17 (0.4, 1.6) | 1.33 (0.0 to 2.2) | 4.41 (2.3 to 7.1) | 0.71 (0.4 to 1.6) | 0.31 (0.0 to 0.7) | 0.84 (0.0 to 1.5) | 1.42 (0.4 to 2.2) | 1.25 (0.0 to 2.4) | 0.72 (0.3 to 1.1) |
Change | −0.20 (−0.8, 1.1) | −0.08 (−1.3 to 1.3) | 0.11 (−3.4 to 4.0) | −0.16 (−0.7 to 0.7) | 0.00 (−0.6 to 0.0) | −0.15 (−0.6 to 0.7) | 0.00 (−0.7 to 0.4) | −0.02 (−1.5 to 1.5) | −0.07 (−1.2 to 0.7) |
p-Value (change ≠ 0)b | 0.631 | 0.683 | 0.879 | 0.477 | 0.107 | 0.740 | 0.898 | 0.903 | 0.658 |
Samples with undetectable levels were imputed half of the detection limit; participants with undetectable levels before and after swimming were excluded.
Wilcoxon test.